Terms: = Uterine cancer AND FGFR3, CD333, 2261, ENSG00000068078, P22607, JTK4, ACH, HSFGFR3EX, CEK2 AND Prognosis
8 results:
1. The impact of adjuvant vaginal brachytherapy in women with Stage II uterine endometrioid carcinoma: Results of a National cancer Database analysis.
Lee JK; Ghanem AI; Modh A; Burmeister C; Mahmoud O; Maxwell GL; Elshaikh MA
Brachytherapy; 2018; 17(2):319-325. PubMed ID: 29174935
[TBL] [Abstract] [Full Text] [Related]
2. Expression of fibroblast growth factor receptor family members is associated with prognosis in early stage cervical cancer patients.
Choi CH; Chung JY; Kim JH; Kim BG; Hewitt SM
J Transl Med; 2016 May; 14(1):124. PubMed ID: 27154171
[TBL] [Abstract] [Full Text] [Related]
3. Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial cancer: Safety and Efficacy.
De Marzi P; Bergamini A; Luchini S; Petrone M; Taccagni GL; Mangili G; Colombo G; Candiani M
J Minim Invasive Gynecol; 2015; 22(7):1178-82. PubMed ID: 26092080
[TBL] [Abstract] [Full Text] [Related]
4. Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative.
Stelloo E; Bosse T; Nout RA; MacKay HJ; Church DN; Nijman HW; Leary A; Edmondson RJ; Powell ME; Crosbie EJ; Kitchener HC; Mileshkin L; Pollock PM; Smit VT; Creutzberg CL
Mod Pathol; 2015 Jun; 28(6):836-44. PubMed ID: 25720322
[TBL] [Abstract] [Full Text] [Related]
5. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.
Gungorduk K; Ertas IE; Sahbaz A; Ozvural S; Sarica Y; Ozdemir A; Sayhan S; Gokcu M; Yilmaz B; Sanci M; Inan S; Harma M; Yildirim Y
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():147-52. PubMed ID: 24965996
[TBL] [Abstract] [Full Text] [Related]
6. CyclinD1, a prominent prognostic marker for endometrial diseases.
Liang S; Mu K; Wang Y; Zhou Z; Zhang J; Sheng Y; Zhang T
Diagn Pathol; 2013 Aug; 8():138. PubMed ID: 23947899
[TBL] [Abstract] [Full Text] [Related]
7. Clinicophathologic characteristics and treatment of small cell carcinoma of uterine cervix.
Yu A; Zhang P; Lou H
Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):400-3. PubMed ID: 12408776
[TBL] [Abstract] [Full Text] [Related]
8. Fibroblast growth factor receptor 3 (fgfr3) - analyses of the S249C mutation and protein expression in primary cervical carcinomas.
Dai H; Holm R; Kristensen GB; Abeler VM; Børresen-Dale AL; Helland A
Anal Cell Pathol; 2001; 23(2):45-9. PubMed ID: 11904459
[TBL] [Abstract] [Full Text] [Related]
